Education
About Us
Working with TipRanks
Follow Us
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
Total Valuation
Coya Therapeutics, Inc. has a market cap or net worth of ―. The enterprise value is $35.51M.
Market Cap―
Enterprise Value$35.51M
Share Statistics
Coya Therapeutics, Inc. has 16,724,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,724,998
Owned by Insiders6.09%
Owned by Institutions19.70%
Financial Efficiency
Coya Therapeutics, Inc.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.04%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-0.04%
Return on Capital Employed (ROCE)-0.43
Revenue Per Employee444.25K
Profits Per Employee-1.86M
Employee Count8
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coya Therapeutics, Inc. is -5.87. Coya Therapeutics, Inc.’s PEG ratio is 0.00.
PE Ratio-5.87
PS Ratio0.00
PB Ratio5.33
Price to Fair Value<0.01
Price to FCF-113.06
Price to Operating Cash Flow-113.06
PEG Ratio0.00
Income Statement
In the last 12 months, Coya Therapeutics, Inc. had revenue of 3.55M and earned -14.88M in profits. Earnings per share was -0.98.
Revenue3.55M
Gross Profit3.55M
Operating Income-17.25M
Pretax Income-15.60M
Net Income-14.88M
EBITDA-17.22M
Earnings Per Share (EPS)-0.98
Cash Flow
In the last 12 months, operating cash flow was -2.84B and capital expenditures -25.00K, giving a free cash flow of -2.84B billion.
Operating Cash Flow-2.84B
Free Cash Flow-2.84B
Free Cash Flow per Share-169.85
Dividends & Yields
Coya Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change-25.42%
50-Day Moving Average5.81
200-Day Moving Average6.32
Relative Strength Index (RSI)39.98
Average Volume (3m)38.12K
Important Dates
Coya Therapeutics, Inc. upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Coya Therapeutics, Inc. as a current ratio of 11.59K, with Debt / Equity ratio of 0.00%
Current Ratio11.59K
Quick Ratio11.59K
Debt to Market Cap0.00
Net Debt to EBITDA2.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Coya Therapeutics, Inc. has paid -720.00K in taxes.
Income Tax-720.00K
Effective Tax Rate0.05
Enterprise Valuation
Coya Therapeutics, Inc. EV to EBITDA ratio is -2.84, with an EV/FCF ratio of -4.76.
EV to Sales13.78
EV to EBITDA-2.84
EV to Free Cash Flow-4.76
EV to Operating Cash Flow-4.76
Balance Sheet
Coya Therapeutics, Inc. has $35.53B in cash and marketable securities with $0.00 in debt, giving a net cash position of -$35.53B billion.
Cash & Marketable Securities$35.53B
Total Debt$0.00
Net Cash-$35.53B
Net Cash Per Share-$2.12K
Tangible Book Value Per Share$2.60
Margins
Gross margin is 0.00%, with operating margin of -485.35%, and net profit margin of -418.70%.
Gross Margin0.00%
Operating Margin-485.35%
Pretax Margin-438.96%
Net Profit Margin-418.70%
EBITDA Margin-484.58%
EBIT Margin-485.35%
Analyst Forecast
The average price target for Coya Therapeutics, Inc. is $17.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.67
Price Target Upside213.85% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-40.79%
EPS Growth Forecast-16.57%